课题基金 / 基金详情

Early Identification Of Developmental Delay Among Infants And Toddlers With Sickle Cell Disease

Early Identification Of Developmental Delay Among Infants And Toddlers With Sickle Cell Disease
早期识别患有镰状细胞病的婴儿和幼儿发育迟缓
批准号:
10590311
负责人:
Catherine Rose Hoyt
金额:
$12.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-01 至 2028-06-30
关键词:
3 year oldAcademyAddressAdultAffectAfrican ancestryAgeAge MonthsAmericanAmerican Society of HematologyAssessment toolAwardBlack raceCaregiversChildChild DevelopmentChild RearingChild WelfareChild health careClinical ResearchCognitionCognitiveCollaborationsComplexDataDevelopmentDevelopment PlansDevelopmental Delay DisordersDiagnosisDoctor of PhilosophyEarly InterventionEarly identificationEducationEducational CurriculumEducational InterventionEnvironmentEvaluationEvidence based interventionFamilyFamily memberFundingFutureGoalsGrantGuidelinesHealthHealthcare SystemsHomeHome environmentHome visitationHumanImpaired cognitionIncidenceInfantInfant DevelopmentInfectionInflammationInheritedInstitutional RacismInterventionInterviewLaboratoriesLifeLongevityMeasuresMedical Care TeamMendelian disorderMental HealthMentored Patient-Oriented Research Career Development AwardMentorsMethodsMissouriNamesNational Heart, Lung, and Blood InstituteNeuronal PlasticityNewborn InfantNursery SchoolsOccupational TherapistOutcomeOutcome MeasurePainParentsPediatric HospitalsPediatricsPersonsPilot ProjectsPopulationPovertyPreparationPreventionProtocols documentationRandomized, Controlled TrialsReadinessRecommendationRehabilitation therapyResearchSchool-Age PopulationSchoolsScientistSeveritiesSickle CellSickle Cell AnemiaStrokeTestingTherapeutic InterventionTimeToddlerTrainingUnemploymentUnited StatesVisitWorkcareercareer developmentcaregiver educationcaregiver interventionscognitive developmentcohortcomparison controlcomparison groupcost effective interventionearly experiencefeasibility testingimplementation scienceimplementation strategyimprovedimproved outcomeinfancyinnovationmultidisciplinarypatient populationpeerprogramsprospectiverecruitresearch and developmentscale upscreeningservice interventionskillssocial culturestandardize measuresuccessteachertheoriestherapeutically effectivetherapy developmenttrial design

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT This K23 application proposes a research and career development plan for Catherine Hoyt, PhD, OTD to establish herself as an independent rehabilitation scientist focused on the early identification and intervention for developmental deficits among infants and toddlers with sickle cell disease (SCD). SCD is the most common monogenic disorder in humans and is primarily inherited by who identify as Black or of African descent. Complications associated with SCD (e.g., infection, pain, stroke) are common in the first years of life. In our earlier work, we found that developmental deficits were present in > 50% of children with SCD before the age of 3 but are none had been diagnosed or referred to intervention services. Further, children whose caregivers participated in a home-based caregiver education program demonstrated improved test scores on standardized measures. Thus, when developmental deficits are overlooked, children miss a critical opportunity for intervention that could improve their developmental trajectory. The American Society of Hematology (ASH) recommends frequent developmental screening starting in the first years of life for all children with SCD. Yet few, if any, studies have described the incidence and severity of developmental deficit among children with SCD compared to controls. Consistent with the American Academy of Pediatrics (AAP) guidelines, this research will evaluate children with SCD at 9, 18, and 30 months using the best available developmental measure, the Bayley Scales of Infant Development-4 (Bayley), to determine the incidence of developmental deficit over the first 3 years of life compared to demographically match peers (n = 100, Aim 1). If developmental deficits are identified, scores will be shared with the child's healthcare team so they can be addressed. Based on theory and evidence, the proposed study will also test a multi-component Sickle Cell Collaboration for Child Development (SCCCD) intervention. The SCCCD combines skilled therapeutic intervention to address developmental deficits, the Parents as Teachers® curriculum and specific SCD education. Our innovative SCCCD intervention is adapted from a pilot study and will provide 12 home visits to caregivers and children with SCD over the course of 1 year (n = 25, Aim 2). Interviews with caregivers who participated, as well as those who declined, will identify contextual determinants (i.e., facilitator and barriers) to prepare for future testing and scaling up of the SCCCD intervention (Aim 3). The results from this K23 award will provide data to understand the onset of developmental deficit in this understudied population and identify the next steps to conduct a randomized control trial to test our SCCCD intervention in an R01 level grant submission. These mentored research aims, combined with a career development plan for advanced training in implementation science (Goal A), mixed methods (Goal B), prospective trial design (Goal C) and professional development (Goals D, E) will enable Dr. Hoyt to launch a career as an independent scientist.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金